Name: Protara Therapeutics, Inc. (TARA) Balance Sheet
Creator: FinSpry

Protara Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Protara Therapeutics, Inc. (TARA) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	162.80	39.59	24.13	35.72	168.60
Short-Term Investments	7.49	25.99	60.24	55.51	0.00
Cash & Short-Term Investments	170.29	65.58	84.37	91.23	168.60
Accounts Receivable	0.00	0.24	0.49	0.63	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.00	0.04	0.59	0.53	1.66
Total Current Assets	172.16	68.71	86.15	93.11	169.44
Non-Current Assets
Property, Plant & Equipment (Net)	5.28	6.56	7.87	8.89	2.30
Long-Term Investments	0.00	0.00	17.89	39.47	0.00
Goodwill	0.00	0.00	0.00	29.52	29.52
Intangible Assets	3.25	2.66	0.08	0.00	0.00
Other Non-Current Assets	0.77	0.76	1.31	1.61	1.91
Total Non-Current Assets	9.30	10.25	26.50	79.48	33.72
Total Assets	181.45	78.95	113.29	172.60	203.16
Current Liabilities
Accounts Payable	4.43	2.43	1.59	0.95	2.83
Short-Term Debt	1.12	0.00	0.00	0.00	0.00
Accrued Liabilities	2.88	0.62	3.24	2.49	1.75
Other Current Liabilities	5.41	2.11	0.00	0.00	0.00
Total Current Liabilities	10.96	6.15	5.74	4.30	2.92
Non-Current Liabilities
Long-Term Debt	3.36	4.48	5.47	6.38	1.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	3.36	4.48	5.47	6.38	1.00
Total Liabilities	14.32	10.63	11.21	10.68	3.91
Stockholders' Equity
Common Stock	0.04	0.01	0.01	0.01	0.01
Retained Earnings	-244.98	-200.38	-159.96	-94.01	-46.76
Accumulated Other Comprehensive Income	0.00	-0.03	-0.69	-0.21	0.00
Additional Paid-in Capital	412.08	268.73	262.72	256.13	245.99
Shares Outstanding	35.04	11.36	11.27	11.24	0.00
Total Stockholders' Equity	167.13	68.32	102.08	161.91	199.24
Total Liabilities & Equity	181.45	78.95	113.29	172.60	203.16